The impact of the COVID‐19 pandemic on perioperative chemotherapy for breast cancer

Abstract Background Since it was first reported in December 2019, coronavirus disease 2019 (COVID‐19) spread rapidly across the globe resulting in a pandemic. As of August 2022, seven outbreak peaks have been confirmed in Tokyo, and the numbers of new cases in the fifth and later outbreak periods ha...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Cancer Medicine
المؤلفون الرئيسيون:	Kaede Baba, Megumi Kawamoto, Kanako Mamishin, Mao Uematsu, Hikari Kiyohara, Akira Hirota, Nobuyuki Takahashi, Misao Fukuda, Shota Kusuhara, Hiromichi Nakajima, Chikako Funasaka, Takehiro Nakao, Chihiro Kondoh, Kenichi Harano, Nobuaki Matsubara, Yoichi Naito, Ako Hosono, Toshikatsu Kawasaki, Toru Mukohara
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2023-06-01
الموضوعات:	adjuvant chemotherapy breast cancer COVID‐19 neoadjuvant chemotherapy SARS‐CoV‐2
الوصول للمادة أونلاين:	https://doi.org/10.1002/cam4.5898